Literature DB >> 2657463

Immunoreactivity of neuronal lipofuscin with monoclonal antibodies to the amyloid beta-protein.

C Bancher1, I Grundke-Iqbal, K Iqbal, K S Kim, H M Wisniewski.   

Abstract

Monoclonal antibodies generated against a synthetic peptide corresponding to amino acids 1 to 24 of cerebrovascular amyloid beta-protein do not only stain amyloidotic blood vessels and the amyloid deposits of the (senile) neuritic plaques, but also the neuronal pigment lipofuscin. Staining of lipofuscin is observed in both cerebral and cerebellar cortices, subcortical nuclei as well as the brain stem, and is identical in Alzheimer and normal control brain. Western blots of a lipofuscin enriched fraction show an anti-beta-protein reactive polypeptide migrating at approximately 31 kDa position on SDS-polyacrylamide gel electrophoresis. These results suggest that this polypeptide is associated with lipofuscin and is most likely derived from the predicted amyloid precursor protein. This implicates that, unlike in Alzheimer's disease where this protein is also processed extraneuronally in a manner to release an amyloid fiber forming fragment, the end point of its processing in the nerve cell seems to accumulate on a lipopigment characteristic for normal aging.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2657463     DOI: 10.1016/0197-4580(89)90021-3

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  22 in total

1.  Immunohistochemical localization of the proteinase inhibitor region of amyloid precursor proteins in the neocortex of Alzheimer's disease and aged controls.

Authors:  S Nakamura; T Suenaga; I Akiguchi; J Kimura; S Nakamura; Y Tokushima; N Kitaguchi; Y Takahashi; S Shiojiri
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 2.  Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.

Authors:  K Iqbal; I Grundke-Iqbal
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

3.  Alzheimer's disease brain-derived ubiquitin has amyloid-enhancing factor activity: behavior of ubiquitin during accelerated amyloidogenesis.

Authors:  K Alizadeh-Khiavi; J Normand; S Chronopoulos; Z Ali-Khan
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

4.  Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brain.

Authors:  H Funato; M Yoshimura; T Yamazaki; T C Saido; Y Ito; J Yokofujita; R Okeda; Y Ihara
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

5.  Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease.

Authors:  H M Wisniewski; C Bancher; M Barcikowska; G Y Wen; J Currie
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Treatment of Stargardt disease with dobesilate.

Authors:  Pedro Cuevas; Luis A Outeiriño; Javier Angulo; Guillermo Giménez-Gallego
Journal:  BMJ Case Rep       Date:  2012-10-12

7.  Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.

Authors:  Matthew J Winton; Edward B Lee; Eveline Sun; Margaret M Wong; Susan Leight; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

Review 8.  Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease.

Authors:  Gunnar K Gouras; Davide Tampellini; Reisuke H Takahashi; Estibaliz Capetillo-Zarate
Journal:  Acta Neuropathol       Date:  2010-03-31       Impact factor: 17.088

9.  Neurofibrillary tangles in some cases of dementia pugilistica share antigens with amyloid beta-protein of Alzheimer's disease.

Authors:  D Allsop; S Haga; C Bruton; T Ishii; G W Roberts
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

10.  Evidence for lysosomal processing of amyloid beta-protein precursor in cultured cells.

Authors:  G M Cole; T V Huynh; T Saitoh
Journal:  Neurochem Res       Date:  1989-10       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.